CPA Supports FEOC Excise Tax in President Trump’s “One Big Beautiful Bill” to Strengthen U.S. Solar Industry and National Security

CPA Supports FEOC Excise Tax in President Trump’s “One Big Beautiful Bill” to Strengthen U.S. Solar Industry and National Security

CPA strongly endorses the FEOC Excise Tax in the Senate reconciliation bill as a critical step in protecting America’s solar manufacturing industry from reliance on subsidized and compromised Chinese components.

CPA Warns Senate Bill Contains Dangerous “Loophole” Benefiting China’s Solar Industry

CPA Warns Senate Bill Contains Dangerous “Loophole” Benefiting China’s Solar Industry

CPA warned that the Senate version of President Trump’s reconciliation bill—known as the One Big Beautiful Bill—contains a critical loophole in both the Section 48E investment tax credit and 45Y production tax credit in the Inflation Reduction Act (IRA), creating an unintended but dangerous giveaway to China’s solar industry.

How to Make Tariffs Work for National Security, Enforcement, and Revenue

How to Make Tariffs Work for National Security, Enforcement, and Revenue

The two Trump Administrations have reshaped the debate on U.S. trade policy. For the first time in decades, U.S. officials are no longer endorsing the “free trade” orthodoxy that has contributed to the erosion of its manufacturing sector. Instead, tariffs are now the centerpiece of U.S. plans to repatriate supply chains and reindustrialize America.

Rechenberg: Thanks to Imported Drugs, America Has Lost Control of Its Medicine Cabinet

Rechenberg: Thanks to Imported Drugs, America Has Lost Control of Its Medicine Cabinet

America is facing a growing crisis in its medical system — not from a lack of talent or innovation, but from a breakdown in the control, safety and supply of essential medicine. Our growing reliance on imports is now driving serious drug shortages, destabilizing supply chains and increasingly making medications unsafe.

America’s Drug Shortage Isn’t a Supply Problem—It’s a Production Crisis

America’s Drug Shortage Isn’t a Supply Problem—It’s a Production Crisis

In the U.S. today, frontline cancer treatments are being rationed. ERs are short on sedatives. Amoxicillin—one of the most prescribed antibiotics in the country—has been in critical shortage. These are not temporary disruptions. They reflect a structural breakdown caused by the erosion of America’s pharmaceutical manufacturing base and a decades-long surge in generic drug imports.

Bessent Defends Tariffs in Senate Hearing, Calls Critics Sufferers of “Tariff Derangement Syndrome”

Bessent Defends Tariffs in Senate Hearing, Calls Critics Sufferers of “Tariff Derangement Syndrome”

Treasury Secretary Scott Bessent stepped into somewhat hostile territory in the Senate Finance Committee hearing on Thursday. But despite dramatic criticism from Ranking Member Ron Wyden (D-OR) and other top Democrats on the Committee, Bessent took an early victory lap on tariffs.

Generic Drugs Need Government Support, House Health Subcommittee Admits

Generic Drugs Need Government Support, House Health Subcommittee Admits

U.S. based generic drug makers need government support to expand – and maybe even to survive – the onslaught of imports nearly every member of the House Energy and Commerce Committee Subcommittee on Health said in a hearing on Wednesday.